Dec 6, 2019
Weighing the impact of key influencers, a recent report published by Fact.MR infers that, the arthritis therapeutics market is estimated to grow 1.5X during the forecast period (2020 - 2027).

Rockville, United States - December 6, 2019 /MarketersMedia/ —
Rapid emergence of biologics presents new commercial opportunities for players in the arthritis therapeutics market. The adoption of biologic drugs is high, especially in developed countries of North America, Europe, and Asia Pacific, given the influence of favourable reimbursement scenarios that cushion the high cost.
In North America and Europe, the presence of public and private medical insurance plans encourages patients to avail quality healthcare. However, in developing countries of Asia Pacific, the out-of-pocket payment model is dominant in the healthcare industry, which is leading to sluggish growth of the arthritis therapeutics market in India and China. In addition, the penetration of generic drugs is high in developing countries of Asia Pacific, owing to their competitive prices.
A comprehensive study published by Fact.MR projects the arthritis therapeutics market to register 7.3% growth in 2020, over 2019.
Request Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=4355
Key Takeaways of Arthritis Therapeutics Market Study
- Constant rise in the prices of popular drugs such as Humira and Enbrel could shift the focus of patients towards complementary and alternative therapies, thereby narrowing the growth of the arthritis therapeutics market. The impact of this trend will be relatively high in developing countries of Asia Pacific such as India and China, as these regions are characterized by high inclination towards natural and herbal therapies.
- Patent expiration of blockbuster drugs in the arthritis therapeutics market are pushing manufacturers to increase investments towards the development of effective drugs, which is projected to fuel the advancements of biosimilar products.
High precision of drugs offered by arthritis therapeutics is projected to maintain patients’ inclination towards parenteral route of administration during the forecast period.
- In 2020, retail pharmacies are projected to account for 79% of the total sales of arthritis therapeutics, as the high concentration of this channels across key locations makes it convenient for patients to purchase the required drugs. However, sales through online pharmacies will gain traction, owing to attractive discounts and convenience offered.
A key opinion leader at Fact.MR portends, “Demand for interleukin inhibitors is outperforming TNF inhibitors in terms of efficacy. In future, with effective marketing efforts by manufacturers, patients will turn more receptive to these novel biologic products.”
Request Research Methodology- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4355
R&D Remains Key Strength of Global Players; Regional Players Excel through Robust Distribution Networks
The arthritis therapeutics market, characterized by consolidation, is dominated by AbbVie Inc., Johnson & Johnson, Amgen Inc., and Novartis Inc. Development of blockbuster drugs enables these leading players to gain an edge over regional and local players. For instance, 33% of share in the arthritis therapeutics market accounted by AbbVie is attributable to its flagship product - Humira, which recorded sales corresponding to a value of US$ 20 Bn in 2018.
On similar lines, Johnson & Johnson strives to diversify its product portfolio through the introduction of effective therapeutics. The company is highly recognized for the launch of Simponi, Tremfya, and Stelara. Distribution channels remain the key strength of regional players. For instance, Eli Lily and Company offers most of its products around the world, and executes effective marketing strategies to position its products in various countries to meet unmet local needs.
Have Any Query? Ask Our Analysts- https://www.factmr.com/connectus/sample?flag=AE&rep_id=4355
Find More Valuable Insights on Arthritis Therapeutics Market
Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global arthritis therapeutics market, presenting historical demand data (2017-2019), and forecast statistics for the period of 2020-2027. The study divulges compelling insights on the arthritis therapeutics market on the basis of type (rheumatoid arthritis, gout, psoriatic arthritis, osteoarthritis, and others), drug class (TNF inhibitors, interleukin inhibitors, NSAIDs, corticosteroids, xanthine oxidase inhibitors, and others), route of administration (parenteral, topical, and oral), and distribution channel (online pharmacies, hospital pharmacies, and retail pharmacies), across five major regions.
To Get more information on Arthritis Therapeutics Market, visit- https://www.factmr.com/report/4355/arthritis-therapeutics-market
About the Healthcare Division at Fact.MR
The healthcare team at Fact.MR assists clients with unique business intelligence needs on a global level. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analysed the healthcare industry to a micro-level across 50+ countries for over a decade. The team provides end-to-end research and consulting services to help keep clients at the top of the game. Reach out to us to know how we can help.
Contact Info:
Name: James Hilton
Email: Send Email
Organization: Fact.MR
Website: https://www.factmr.com/
Source: MarketersMedia
Release ID: 88937926
The firm also announced a new system to track, investigate and disclose cases of models misbehaving, or "misalignment".
Katy Watson explores Australia's relationship with China - partner, rival or 'frenemy'?
Rates were hiked in a unanimous decision despite fierce opposition from President Donald Trump, who had called for a cut.
The 0.25% increase comes despite fierce opposition from the US president, who has called for rates to be cut.
Trump, who has frequently clashed with Canada's PM, threatens to cut trade with the European Union in response to the proposal.
Evan Spiegel says it would be "an important step forward for the industry" in an interview with the BBC.
Nvidia, OpenAI and Anthropic are all now selling their own limited edition fashion lines.
US Fed hikes rates for first time since 2023 as inflation stays sticky
The BBC's Samira Hussain looks at the factors considered in the increase by the Federal Reserve and what it could mean for the US economy.
The BBC goes inside a fortified storage facility to view luxury goods seized by police that are now up for auction.
Mr. Hamm’s company, Continental Resources, has signed a preliminary deal with Venezuela’s state-owned oil company to develop and produce oil.
Kevin M. Warsh, the Federal Reserve chairman, said the bank acted to fight inflation that ‘is too high and has been for too long.’
Lower wage growth and slower hiring in some sectors may be the result of artificial intelligence, especially for younger workers.
America’s position of global economic stability is starting to look shakier as the Trump administration piles on debt and doubles down on sanctions.
Elevated interest rates have raised the cost of mortgages and car loans without dampening consumer spending.
Fox is revamping the sports site following the exit of its founder, Clay Travis. It’s hiring a writer who resigned from The Seattle Times over a column about transgender athletes.
The absence of the annual estimate on the tax gap could make it more difficult to assess whether more taxes are going unpaid since President Trump took office.
The Treasury secretary and the Federal Reserve chairman face similar tests: calming investors’ growing worries about inflation and deficits.
Prolonged restrictions on exports could push oil prices even higher.
The Budget is only six weeks away and the economy is undoubtedly the biggest challenge facing the prime minister.
Summer holidays and disruption to global oil supplies by the Middle East conflict stoked price growth.
The prime minister insists he is prepared to take "difficult decisions" at next month's Budget.
If the Fed opts against raising interest rates on Wednesday, investors will probably increase their forecasts for inflation, injecting new turmoil into the government bond market.
The number of shoplifting offences recorded in England and Wales in 2025-26 is still above pre-pandemic levels.
The Hong Kong Special Administrative Region has unveiled its first five-year plan for economic and social development (2026-2030) on Wednesday.
Graphics: What stood out in China's economy in August?
The Pinglu Canal opens a faster gateway to the sea for China's Guangxi Zhuang Autonomous Region and southwest China's cargo.
Chinese films are gaining momentum in overseas markets, with North America emerging as an important testing ground for their global appeal.
The release of Hong Kong's first five-year plan marks an important milestone in the city's development. By building on its existing strengths and creating new opportunities through planning and innovation, the city can strengthen its competitiveness in a changing global environment.
The 23rd China-ASEAN Expo is set to open in Nanning, south China's Guangxi Zhuang Autonomous Region.
Sam Altman and other tech CEOs say there are incentives to limit advancements in AI, as fears grow over the threats it poses to humanity.
Chinese mainland welcomes Taiwan to Pinglu Canal opportunities
UK inflation rose in August, pushed up by higher petrol and diesel prices.
Ellen Pollock, who has spent nearly a decade in charge of the Business desk of The Times, is ready for a new challenge.
A recent high-profile shooting outside a mosque and rising threats to houses of worship have focused attention on security guards. Now, unions are pressing for better pay and training.
Generic questions get generic answers, experts say, so to avoid mediocre recommendations, you’ll need to write smarter prompts. Follow these tips.
For dozens of editors and reporters, the anniversary of the first issue of The Times in 1851 has been a moment to look back.
Four recent job starters share their tips on what helped them have a smooth transition and survive their first few days.
China's Hong Kong Special Administrative Region has never lacked ambition when it comes to urban development.
AI governance should be a shared global responsibility and that developing countries should have opportunities to participate in and benefit from AI development.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.